Literature DB >> 8762870

Molecular changes in oral cancer may reflect aetiology and ethnic origin.

I C Paterson1, J W Eveson, S S Prime.   

Abstract

Oral cancer, although uncommon in the Western world, accounts for up to 40% of all malignancies in parts of India and South East Asia. Recognised aetiological agents of oral cancer include tobacco and alcohol. This paper reviews the spectrum of molecular changes found in oral squamous cell carcinomas from Western (U.K., U.S.A., Australia) and Eastern (India, S.E. Asia) countries. p53 mutations are common in tumours from the West (47%) but are infrequent in the East (7%). Tumours from India and South East Asia are characterised by the involvement of ras oncogenes, including mutation, loss of heterozygosity (H-ras) and amplification (K- and N-ras), events which are uncommon in the West. The possibility that these genetic differences reflect aetiology and/or ethnic origin is discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8762870     DOI: 10.1016/0964-1955(95)00065-8

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  23 in total

1.  Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.

Authors:  Eleftherios Vairaktaris; Georgios Papageorgiou; Spyridoula Derka; Panagiota Moulavassili; Emeka Nkenke; Peter Kessler; Stavros Vassiliou; Veronica Papakosta; Sofia Spyridonidou; Antonis Vylliotis; Andreas C Lazaris; Sofia Anagnostopoulou; Constantinos Mourouzis; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-28       Impact factor: 4.553

2.  Overexpression of autophagy-related 16-like 1 in patients with oral squamous cell carcinoma.

Authors:  Jen-Yang Tang; Edward Hsi; Ya-Chun Huang; Nicholas Chung-Heng Hsu; Wen-Chi Yang; Hsueh-Wei Chang; Chee-Yin Chai; Pei-Yi Chu
Journal:  Pathol Oncol Res       Date:  2014-07-25       Impact factor: 3.201

3.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

4.  Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.

Authors:  E C Torchia; C Caulin; S Acin; T Terzian; B J Kubick; N F Box; D R Roop
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

5.  Quantitative Assessment of Tumor Associated Macrophages in Head and Neck Squamous Cell Carcinoma Using CD68 Marker: An Immunohistochemical Study.

Authors:  Neeta Bagul; Souparna Roy; Anjali Ganjre; Rahul Kathariya; Aishwarya Meher; Pratibha Singh
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 6.  Lessons learned from next-generation sequencing in head and neck cancer.

Authors:  Myriam Loyo; Ryan J Li; Chetan Bettegowda; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Nishant Agrawal
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

Review 7.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

8.  Squamous cell carcinoma of tongue and buccal mucosa: clinico-pathologically different entities.

Authors:  Sudhir Nair; Bikramjit Singh; Prashant V Pawar; Sourav Datta; Deepa Nair; Shubhada Kane; Pankaj Chaturvedi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-20       Impact factor: 2.503

9.  Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression.

Authors:  Swapnali Pathare; Alejandro A Schäffer; Niko Beerenwinkel; Manoj Mahimkar
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

10.  A genetic variant of Aurora kinase A promotes genomic instability leading to highly malignant skin tumors.

Authors:  Enrique C Torchia; Yiyun Chen; Hong Sheng; Hiroshi Katayama; James Fitzpatrick; William R Brinkley; Carlos Caulin; Subrata Sen; Dennis R Roop
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.